Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer-Reference-Cited by-同舟云学术

Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer

Published:2012-12 Issue:3 Volume:105 Page:299-304
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Guerra Jose Luis Lopez,Gomez Daniel,Wei Qingyi,Liu Zhengshen,Wang Li-E,Yuan Xianglin,Zhuang Yan,Komaki Ritusko,Liao Zhongxing

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference23 articles.

1. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999

2. Dosimetric and clinical predictors for radiation-induced esophageal injury;Ahn;Int J Radiat Oncol Biol Phys,2005

3. Esophagus in-field: a new predictor for esophagitis;Caglar;Radiother Oncol,2010

4. Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial;Jensen;Cancer,2011

5. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer;Sejpal;Cancer,2011

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiogenomics in lung cancer: Where are we?;Lung Cancer;2023-02

2. Radiation Therapy-Related Toxicity: Esophagus;Medical Radiology;2023

3. Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy;Frontiers in Oncology;2022-11-22

4. Improving Patients’ Life Quality after Radiotherapy Treatment by Predicting Late Toxicities;Cancers;2022-04-22

5. Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes;Frontiers in Oncology;2021-06-24